IL22 and psoriasis: To assess the function of PI3Kδ in psoriasis skin, we evaluated the effects of a potent, ATP-competitive, and selective PI3Kδ inhibitor—seletalisib—on the key intracellular pathways known to be activated by IL-22 or TNF-α in human keratinocytes.